Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

ABL Diagnostics to acquire IntegraGen

PRIVATESep 11, 2026•about 3 hours ago

Acquiring Company

ABL Diagnostics

Acquired Company

IntegraGen

Grand EstFranceBiotechnologyBiotechnologyHealth CareGeneticsBioinformatics

Description

ABL Diagnostics has filed a takeover bid to acquire the business operations and assets of IntegraGen. This acquisition aims to enhance ABL Diagnostics' capabilities in genomic solutions. The announcement was made on September 11, 2026.

Company Information

Company

ABL Diagnostics

Location

Grand Est, France

About

ABL Diagnostics is an international company specializing in innovative molecular biology tests. It offers solutions in molecular detection and genotyping services. ABL markets its products globally through sales teams and exclusive distributors. The company is focused on expanding its portfolio in microbiology products.

Don't miss ABL Diagnostics's next move

Get an email the moment ABL Diagnostics makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Dimitri
Senior decision-maker at this company
••••••••@••••••••

See Dimitri's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for ABL Diagnostics's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired IntegraGen?

IntegraGen was acquired by ABL Diagnostics, based in Grand Est. The deal was reported on September 11, 2026. ABL Diagnostics is an international company specializing in innovative molecular biology tests. It offers solutions in molecular detection and genotyping services. ABL Diagnostics is privately held and operates in Biotechnology.

When did ABL Diagnostics acquire IntegraGen?

ABL Diagnostics's acquisition of IntegraGen was reported on September 11, 2026. ABL Diagnostics has filed a takeover bid to acquire the business operations and assets of IntegraGen. This acquisition aims to enhance ABL Diagnostics' capabilities in genomic solutions. The announcement was made on September 11, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does IntegraGen do?

IntegraGen is a company within the OncoDNA Group specializing in cancer genomics and rare genetic diseases. It leverages highly qualified and experienced teams to provide major services in DNA sequencing and genomic data interpretation software. It is privately held, operating in Biotechnology, and is based in France.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.